|
[Related PubMed/MEDLINE]
Total Number of Papers: 18
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: SD |
| Long Form |
: stabilization of disease |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Multi-center, randomized, double-blind, placebo-controlled, exploratory study to evaluate the efficacy and safety of HAD-B1 for dose-finding in EGFR positive and locally advanced or metastatic NSCLC subjects who need Afatinib therapy: Study protocol clinical trial (SPIRIT Compliant). |
AR, CR, DCRs, EGFR, NSCLC, PFS, PR, QOL, TKIs, TTP |
| 2 |
2019 |
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis. |
AE, ASCT, NHL, ORR, PD, PFS and OS, PLRG |
| 3 |
2014 |
Is there a role for second-line platinum re-challenge in advanced biliary tract cancers? |
DCR, GemCis, PR |
| 4 |
2014 |
Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response? |
AE, PR |
| 5 |
2013 |
[Attainment of complete hematological remission is crucial for extended survival of AL amyloidosis patients with cardiac involvement]. |
CR, PR |
| 6 |
2011 |
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours. |
GIST, MTD, PR |
| 7 |
2010 |
[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]. |
DTH, HRPC, PAP, PD, PR, PSA, PSMA |
| 8 |
2006 |
Stable disease in advanced colorectal cancer: therapeutic implications. |
5-FU, OS, PD, RR, TTP |
| 9 |
2005 |
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature. |
--- |
| 10 |
2005 |
Therapy of aggressive fibromatosis is still an open question: a series of patients treated at a single institution. |
CR, i.v, PR |
| 11 |
2004 |
A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours. |
MTD, PR |
| 12 |
2004 |
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas. |
CR, MTC |
| 13 |
2002 |
Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study. |
AA, GB, PR |
| 14 |
2000 |
Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients. |
CR, NSCLC, PD, PR |
| 15 |
1999 |
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. |
ELF, MGC, PD, PR |
| 16 |
1990 |
Chemoembolization for hepatocellular carcinoma. |
AFP, CT, HCC, MRs, PD, PRs |
| 17 |
1987 |
Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma. |
MR, rIFN alpha-2C |
| 18 |
1985 |
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council. |
AZQ, CNS, OR |
|
A Search Service for Abbreviation / Long Form
